Andres Maldonado
Stock Analyst at HC Wainwright & Co.
(4.26)
# 452
Out of 5,133 analysts
76
Total ratings
49.33%
Success rate
19.23%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AURA Aura Biosciences | Assumes: Buy | $22 | $5.06 | +334.78% | 1 | May 28, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Reiterates: Buy | $10 | $3.48 | +187.36% | 1 | May 15, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintains: Buy | $50 → $40 | $7.94 | +403.78% | 2 | May 7, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $15 → $10 | $1.17 | +754.70% | 1 | May 7, 2025 | |
| ERAS Erasca | Reiterates: Buy | $6 | $7.51 | -20.05% | 10 | Apr 30, 2025 | |
| FHTX Foghorn Therapeutics | Reiterates: Buy | $13 | $6.68 | +94.61% | 1 | Apr 30, 2025 | |
| STRO Sutro Biopharma | Reiterates: Neutral | $20 | $10.63 | +88.15% | 1 | Apr 29, 2025 | |
| TARA Protara Therapeutics | Reiterates: Buy | $23 | $4.92 | +367.48% | 1 | Apr 28, 2025 | |
| CGON CG Oncology | Reiterates: Buy | $75 | $52.58 | +42.64% | 13 | Apr 28, 2025 | |
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $36 | $10.59 | +239.94% | 14 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $0.57 | +2,525.13% | 16 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $8.38 | +198.33% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $50 | $43.75 | +14.29% | 13 | Nov 26, 2024 |
Aura Biosciences
May 28, 2025
Assumes: Buy
Price Target: $22
Current: $5.06
Upside: +334.78%
Zentalis Pharmaceuticals
May 15, 2025
Reiterates: Buy
Price Target: $10
Current: $3.48
Upside: +187.36%
Corbus Pharmaceuticals Holdings
May 7, 2025
Maintains: Buy
Price Target: $50 → $40
Current: $7.94
Upside: +403.78%
TScan Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $1.17
Upside: +754.70%
Erasca
Apr 30, 2025
Reiterates: Buy
Price Target: $6
Current: $7.51
Upside: -20.05%
Foghorn Therapeutics
Apr 30, 2025
Reiterates: Buy
Price Target: $13
Current: $6.68
Upside: +94.61%
Sutro Biopharma
Apr 29, 2025
Reiterates: Neutral
Price Target: $20
Current: $10.63
Upside: +88.15%
Protara Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $23
Current: $4.92
Upside: +367.48%
CG Oncology
Apr 28, 2025
Reiterates: Buy
Price Target: $75
Current: $52.58
Upside: +42.64%
Day One Biopharmaceuticals
Apr 3, 2025
Reiterates: Buy
Price Target: $36
Current: $10.59
Upside: +239.94%
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $0.57
Upside: +2,525.13%
Mar 11, 2025
Reiterates: Buy
Price Target: $25
Current: $8.38
Upside: +198.33%
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $50
Current: $43.75
Upside: +14.29%